Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05901935 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.
Track this trial| NCT Number | NCT05901935 |
| Lead Sponsor | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. |
| Conditions | HER2-positive Advanced Breast Cancer |
| Enrollment | 420 participants |
| Start Date | 2023-07 |
| Primary Completion | 2026-01 (estimated) |
| Study Completion | 2028-07 (estimated) |
| Updated on ClinicalTrials.gov | 2023-06-13 |